.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The KEYNOTE-826 trial demonstrated that adding pembrolizumab to platinum-based chemotherapy, with or without bevacizumab, improved progression-free survival and overall survival in persistent, recurrent or metastatic cervical cancer. The findings established immune-checkpoint inhibition as an important first-line treatment option for many patients with advanced disease. For gynecologic oncology, biomarker assessment and careful toxicity monitoring are increasingly integrated into treatment planning. Immune-related adverse events can affect endocrine, hepatic, pulmonary and gastrointestinal systems and may require treatment interruption or corticosteroids. The study underscores the shift from chemotherapy-only strategies toward combinations that target both tumor proliferation and antitumor immunity.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The KEYNOTE-826 trial demonstrated that adding pembrolizumab to platinum-based chemotherapy, with or without bevacizumab, improved progression-free survival and overall survival in persistent, recurrent or metastatic cervical cancer. The findings established immune-checkpoint inhibition as an important first-line treatment option for many patients with advanced disease. For gynecologic oncology, biomarker assessment and careful toxicity monitoring are increasingly integrated into treatment planning. Immune-related adverse events can affect endocrine, hepatic, pulmonary and gastrointestinal systems and may require treatment interruption or corticosteroids. The study underscores the shift from chemotherapy-only strategies toward combinations that target both tumor proliferation and antitumor immunity.
4 weeks back
A bioengineered oral nanozyme microsupplement converts pathological ROS into a protective polydopamine hydrogel shield. By curbing neutrophil extracellular traps and balancing T cells, this platform outperforms standard 5-ASA in preclinical colitis models, opening new paths for sustained remission.
4 days back
Recent research reveals that downregulating YAP1/TAZ-TEAD via Hippo signaling triggers spontaneous human trophoblast syncytialization in 3D cultures, illuminating placental biology and preeclampsia.
4 weeks back
Abdominal aortic aneurysm rupture remains a catastrophic vascular emergency. Groundbreaking research reveals that USP53 accelerates aneurysm progression by reprogramming smooth muscle cell metabolism toward aerobic glycolysis, highlighting a promising target beyond conventional diameter-based surveillance.
5 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
5 days back
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
5 days back
